Blood clotting tests may help spot leg clot risk after glioma surgery
Original title: Perioperative coagulation profiling and postoperative lower-extremity venous thrombosis risk prediction in glioma patients.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
It is based on past patient records, and the tool is not yet tested in new patients.
The short version
Researchers looked at blood clotting tests to guess who might get a leg clot after brain tumor surgery.
What was studied. Researchers looked back at the records of people with glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are given a grade from 1 to 4 describing how the tumor is expected to behave. See the glossary and people with other conditions. They studied blood clotting tests taken before and after surgery.
What they found. Blood in people with glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are given a grade from 1 to 4 describing how the tumor is expected to behave. See the glossary clotted more easily than in the other groups, and more so when the tumor did not have a gene change called IDH gene change: A small change in a tumor's IDH gene. It is the first thing your team looks at when naming an adult glioma, and it can affect which treatments are offered. Your pathology report says whether your tumor has it. See the glossary. People who got clots in their leg veins had different clotting test results before and after surgery. The researchers used these results to build a tool that they say predicts leg clot risk well.
What this means, and what it doesn't
What it could mean: Someday, simple blood tests might help doctors find which patients are more likely to get leg clots after surgery. That could help doctors act sooner to prevent them.
What it doesn't mean: This study only looked back at past patient records. The tool has not been tested in new patients yet. Doctors do not use it in everyday care today. It does not prevent or treat clots by itself, and it is not a cure for brain tumors.
Source: PubMed, August 24, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.